Live Breaking News & Updates on Foundation Principal Investigators

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA™
Mateon Therapeutics, Inc.February 16, 2021 GMT
AGOURA HILLS, California, Feb. 16, 2021 (GLOBE NEWSWIRE)  Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, announced a global partnership with Chopra Foundation, a non-profit, to collaborate on research and development of PulmoHeal™ and ARTIVeda™ for COVID-19 and other infectious diseases through joint research between Mateon and Foundation Principal Investigators (PI) from premium US universities.
“We view this collaboration as a cornerstone for the future development of the ARTIVeda™ and PulmoHeal™ brands to make a significant impact on the development of ethnobiology drugs for the treatment of emerging diseases.” said Saran Saund, CBO and GM of A ....

United States , Agoura Hills , United Kingdom , Deepak Chopra , Saran Saund , Amit Shah , Suhas Kshirsagar , Contract Development , Ai Division , Manufacturing Organization , Ayurvedic Healing Inc , Foundation Principal Investigators , Standards Authority Of India , Mateon Therapeutics Inc , Chopra Foundation , Mateon Therapeutics , Food Safety , Standards Authority , Windlas Biotech , Emergency Use Authorization , Ayurvedic Healing , Safety Index , Cautionary Note , Private Securities Litigation Reform Act , Public Health , Products And Services ,